Filariose linfática: doença potencialmente eliminável

Detalhes bibliográficos
Autor(a) principal: Dreyer, Gerusa
Data de Publicação: 1997
Outros Autores: Coelho, Giovanini
Tipo de documento: Artigo
Idioma: por
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/891
Resumo: The recent demonstration that single-dose ivermectin, diethylcarbamazine, or a combination of these drugs can profoundly suppress Wuchereria bancrofti and Brugia malayi microfilaremia for periods of six months to two years has led to renewed hope that transmission can be interrupted and lymphatic filariasis eradicated. Based in part on the availability of these new chemotherapeutic tools, the International Task Force for Disease Eradication recently identified lymphatic filariasis as one of the few diseases that could potentially be eradicated. Thus, control programs based on mass treatment (whether supplemented or not by vector control) have begun to be implemented in some endemic areas. We provide a brief review of available anti-filarial drugs for use in humans, including their tolerance and efficacy.
id FIOCRUZ-5_f6726bb7a95044decf52128c0aef6665
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/891
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Filariose linfática: doença potencialmente eliminávelFilariose LinfáticaControleIvermectinaDietilcarbamazinaWuchereria bancroftiThe recent demonstration that single-dose ivermectin, diethylcarbamazine, or a combination of these drugs can profoundly suppress Wuchereria bancrofti and Brugia malayi microfilaremia for periods of six months to two years has led to renewed hope that transmission can be interrupted and lymphatic filariasis eradicated. Based in part on the availability of these new chemotherapeutic tools, the International Task Force for Disease Eradication recently identified lymphatic filariasis as one of the few diseases that could potentially be eradicated. Thus, control programs based on mass treatment (whether supplemented or not by vector control) have begun to be implemented in some endemic areas. We provide a brief review of available anti-filarial drugs for use in humans, including their tolerance and efficacy.Os resultados obtidos com o uso de esquemas terapêuticos simples, como dose única anual ou bianual de Ivermectina (IV), Dietilcarbamazina (DEC) sozinhas ou combinadas, têm sido surpreendentemente promissores na redução da infecção linfática causada pela Wuchereria bancrofti e Brugia malayi. Assim, perspectivas existem de eliminar a doença dos países endêmicos, se programas de controle forem empregados usando-se o tratamento em massa, complementado ou não pelo controle do vetor. Uma breve revisão é feita sobre cada droga em relação à eficácia e às reações adversas causadas pela morte dos diversos estágios do parasita no homem infectado.Reports in Public HealthCadernos de Saúde Pública1997-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/891Reports in Public Health; Vol. 13 No. 3 (1997): July/SeptemberCadernos de Saúde Pública; v. 13 n. 3 (1997): Julho/Setembro1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/891/1772https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/891/1773Dreyer, GerusaCoelho, Giovaniniinfo:eu-repo/semantics/openAccess2024-03-06T15:26:07Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/891Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:01:06.127790Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv Filariose linfática: doença potencialmente eliminável
title Filariose linfática: doença potencialmente eliminável
spellingShingle Filariose linfática: doença potencialmente eliminável
Dreyer, Gerusa
Filariose Linfática
Controle
Ivermectina
Dietilcarbamazina
Wuchereria bancrofti
title_short Filariose linfática: doença potencialmente eliminável
title_full Filariose linfática: doença potencialmente eliminável
title_fullStr Filariose linfática: doença potencialmente eliminável
title_full_unstemmed Filariose linfática: doença potencialmente eliminável
title_sort Filariose linfática: doença potencialmente eliminável
author Dreyer, Gerusa
author_facet Dreyer, Gerusa
Coelho, Giovanini
author_role author
author2 Coelho, Giovanini
author2_role author
dc.contributor.author.fl_str_mv Dreyer, Gerusa
Coelho, Giovanini
dc.subject.por.fl_str_mv Filariose Linfática
Controle
Ivermectina
Dietilcarbamazina
Wuchereria bancrofti
topic Filariose Linfática
Controle
Ivermectina
Dietilcarbamazina
Wuchereria bancrofti
description The recent demonstration that single-dose ivermectin, diethylcarbamazine, or a combination of these drugs can profoundly suppress Wuchereria bancrofti and Brugia malayi microfilaremia for periods of six months to two years has led to renewed hope that transmission can be interrupted and lymphatic filariasis eradicated. Based in part on the availability of these new chemotherapeutic tools, the International Task Force for Disease Eradication recently identified lymphatic filariasis as one of the few diseases that could potentially be eradicated. Thus, control programs based on mass treatment (whether supplemented or not by vector control) have begun to be implemented in some endemic areas. We provide a brief review of available anti-filarial drugs for use in humans, including their tolerance and efficacy.
publishDate 1997
dc.date.none.fl_str_mv 1997-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/891
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/891
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/891/1772
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/891/1773
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 13 No. 3 (1997): July/September
Cadernos de Saúde Pública; v. 13 n. 3 (1997): Julho/Setembro
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943344268673024

Registros relacionados